Soudy K, Szymanski C, Lalanne C, Bourgault C, Thiounn A, Cotten A, Maynou C
Service d'orthopédie A, Hôpital Roger Salengro, CHRU Lille, rue Emile Laine, 59000 Lille, France.
Service d'orthopédie A, Hôpital Roger Salengro, CHRU Lille, rue Emile Laine, 59000 Lille, France.
Orthop Traumatol Surg Res. 2017 May;103(3):415-420. doi: 10.1016/j.otsr.2016.12.015. Epub 2017 Feb 3.
The objective of this study was to assess clinical and computed-tomography (CT) outcomes at least 2 years after humeral head resurfacing to treat concentric gleno-humeral osteoarthritis.
Humeral head resurfacing provides similar outcomes to those achieved with stemmed humeral head implants.
This single-centre retrospective study included 40 Copeland™ and 65 Aequalis™ humeral resurfacing heads implanted between 2004 and 2012. Mean patient age at diagnosis was 64 years. The diagnoses were osteoarthritis with an intact (68%) or torn (21%) rotator cuff, avascular necrosis (5%), osteoarthritis complicating chronic instability (3%), post-traumatic osteoarthritis (2%), and chronic inflammatory joint disease (1%). Validated clinical scores, radiographs, and CT before surgery and at last follow-up were compared.
During the mean follow-up of 56 months, complications occurred in 24 implants. Revision surgery with reverse shoulder replacement was required in 18 cases, after a mean of 43.6 months, to treat glenoid wear or a rotator cuff tear. At last follow-up, for the implants that did not require revision surgery, the mean Constant score was 64/100. The implants had a mean varus of 5° and mean retroversion of -13.3°. The mean increase in glenoid cavity depth was 2.4mm. Mean increases in medial and lateral humeral offset were 1.9mm and 2.7mm, respectively. Pre-operative factors significantly associated with failure were rotator cuff tear (P=0.017) and glenoid erosion (P=0.001).
We found a high failure rate related to glenoid wear or progressive rotator-cuff impairment, although CT showed no evidence of implant malposition or overstuffing. Previous studies of stemmed humeral head implants showed better outcomes. Given the low medium-term prosthesis survival rate, we now reserve humeral head resurfacing for concentric osteoarthritis without glenoid erosions or rotator cuff damage.
IV, retrospective study.
本研究的目的是评估肱骨头表面置换治疗同心性盂肱关节炎至少2年后的临床和计算机断层扫描(CT)结果。
肱骨头表面置换的结果与带柄肱骨头植入物的结果相似。
这项单中心回顾性研究纳入了2004年至2012年间植入的40个Copeland™和65个Aequalis™肱骨头表面置换假体。诊断时患者的平均年龄为64岁。诊断包括肩袖完整(68%)或撕裂(21%)的骨关节炎、缺血性坏死(5%)、并发慢性不稳定的骨关节炎(3%)、创伤后骨关节炎(2%)以及慢性炎症性关节病(1%)。比较了术前和最后一次随访时经过验证的临床评分、X线片和CT。
在平均56个月的随访期间,24个植入物出现并发症。18例患者在平均43.6个月后需要进行翻修手术,采用反肩置换术来治疗关节盂磨损或肩袖撕裂。在最后一次随访时,对于不需要翻修手术的植入物,Constant平均评分为64/100。植入物的平均内翻角度为5°,平均后倾角度为-13.3°。关节盂腔深度平均增加2.4mm。肱骨头内侧和外侧偏移的平均增加量分别为1.9mm和2.7mm。与失败显著相关的术前因素是肩袖撕裂(P=0.017)和关节盂侵蚀(P=0.001)。
我们发现与关节盂磨损或进行性肩袖损伤相关的失败率很高,尽管CT显示没有植入物位置不当或填充过多的证据。先前关于带柄肱骨头植入物的研究显示出更好的结果。鉴于中期假体生存率较低,我们现在仅将肱骨头表面置换用于无关节盂侵蚀或肩袖损伤的同心性骨关节炎。
IV级,回顾性研究。